论文部分内容阅读
上海医药(集团)总公司系统广大干部、职工认真贯彻党的十五届四中全会精神,结合行业实际,围绕1999年初提出的“塑造公司新形象,突出管理新要求,发展产业新优势,建设医药新高地”的经济工作总方针,坚持创新发展,大力推进产业升级,努力克服医药生产经营面临的各种困难和矛盾,在宏观环境不很宽松的情况下,负重奋进,实现了1999年医药经济工作目标。 该公司1999年完成工业总产值145.1亿元,比上年增长14％;完成销售产值105亿元,比上年增长5％;完成商业销售总额72.2亿元,比上年增长15.7％;产销率达99.2％;完成出口创汇1.86亿美元,比上年增长6.2％;实现利润总额2亿元,比上年增长11％;完成资产投资7.97
The Shanghai Pharmaceutical (Group) Corporation has a system of cadres and employees who conscientiously implement the spirit of the Fourth Plenary Session of the 15th CPC Central Committee and, in line with the actual conditions of the industry, revolves around the “shaping new company image, highlighting new management requirements, and developing new industrial advantages, and building The general principle of economic work in the New Highlands of Medicine, adheres to innovation and development, vigorously promotes industrial upgrading, and strives to overcome various difficulties and contradictions faced by pharmaceutical production and operations. With the macro-environment not very lenient, the company has forged ahead and achieved 1999 medicine. Economic work goals. In 1999, the company achieved a total industrial output value of 14.51 billion yuan, an increase of 14% over the previous year; the sales value of 10.5 billion yuan was completed, an increase of 5% over the previous year; and the total commercial sales amounted to 7.22 billion yuan, an increase of 15.7% over the previous year; 99.2%; Completion of export earnings of 186 million US dollars, an increase of 6.2% over the previous year; Total profit of 200 million yuan, an increase of 11% over the previous year; Completed investment in assets 7.97